Stock Ideas 
Investing Ideas NeoStem Files Milestone Stem Cell Patent
Investing Ideas NeoStem Files Milestone Stem Cell Patent 
Market Watch
| Shares of Cynosure Inc. (CYNO), a maker of aesthetic treatment systems, are up more than 150% so far this year. Revenue is up 59%, and net income is 133% higher over the past six months. | |
| More... |
Most Popular
Login Form
| NeoStem Files Milestone Stem Cell Patent |
| Saturday, 18 August 2007 | ||||||||
|
What if there was a proven process whereby the healthy cells in your body could be collected and stored to treat or cure dozens of debilitating or life-threatening disease that you may develop in the future? Wouldn't you invest in the exponential revenue potential of a Company at the forefront of this bio-revolution? Now you can. As a physician and CEO, I firmly believe that we have great revenue potential for our first-to-market adult stem cell initiatives and products. We believe adult stem cells are an integral part of a next generation of life-saving therapies. NeoStem is on the cutting edge of this revolution and we believe we can deliver significant growth as a result of management's focused plans to aggressively attain market share.Our recently filed wide-reaching patent application relates to a bio-medical infrastructure where NeoStem facilitates the collection, storage and eventual dispensing of an individual's stem cells so as to take advantage of future therapies in the event that serious disease develops. The patent filing also covers the creation of "bio-insurance", which encompasses the extraction of the patient's stem cells from peripheral blood (through a non-invasive, easy-to-administer process). The stem cells are sent to a NeoStem facility to be cryopreserved, stored and characterized. If the insured needs to access his/her own stem cells to combat critical or life threatening disease, they are readily available. Stored in tube-like structures known as aliquots, fractionated stem cells can be made available to address specific diseases. In essence, from storage to the appropriate medical facility, the stem cells can be quickly delivered in a pharmacy-like manner. The patent covers truly revolutionary and low cost initiatives that will not only benefit the multibillion-dollar healthcare system, but also will likely save many lives. As new therapies are developed, stored stem cells may play both a role in clinical trials as well as utilizing new and revolutionary treatments/cures, as they are made available-another significant revenue stream for NeoStem.Our clients will be among the first to benefit from the potentially life saving progress that has already been made for numerous debilitating conditions. In fact, almost a hundred diseases have been the subject of adult stem cell research including those of the autoimmune system, ocular, blood disorders, wounds, and neural degenerative afflictions such as strokes and Parkinson's.
We will continue to look for new and novel ways to utilize adult stem cells and firmly believe that our progress to date positions us to take advantage of this new and developing breed of genetic therapies. Our intention is to rapidly build our patent portfolio to enhance and protect our technologies for the benefit of our shareholders. I look forward to delivering more information to Investors in the weeks to come as we continue to expand on our progress to date. For more information, I would direct you to our comprehensive Investor Center . I thank you for your attention and am confident you will find NeoStem a very worthwhile addition to your portfolio. Best Regards, Robin Smith, MD Chairman and CEO NeoStem Inc. Source : Investment House
|
||||||||
| < Prev | Next > |
|---|
